Today: 13 June 2026
Bank of America stock rises as yields edge up; what could move BAC next week
3 January 2026
1 min read

Bank of America stock rises as yields edge up; what could move BAC next week

NEW YORK, Jan 3, 2026, 1:55 PM ET — Market closed

Bank of America Corp (NYSE: BAC) shares rose 1.73% to close at $55.95 on Friday, tracking gains across major U.S. banks. JPMorgan Chase climbed 1.01%, Wells Fargo gained 2.15% and Citigroup added 1.72%, according to MarketWatch data.

The move came as Treasury yields pushed higher, a shift that often matters for bank stocks because it can change the economics of lending. The benchmark 10-year yield rose 3.8 basis points — a basis point is one-hundredth of a percentage point — to 4.191%, while the 30-year yield climbed to 4.8682%, Reuters reported.

The Dow and S&P 500 ended higher on Friday while the Nasdaq slipped slightly, snapping a four-session losing streak for the blue-chip and broad indexes. With markets closed for the weekend, traders are looking ahead to next week’s labor-market data and the Federal Reserve’s rate outlook. Joe Mazzola, head of trading and derivatives strategist at Charles Schwab, said the mood has been “buy the dip, sell the rip.” Reuters

Bank stocks often react quickly to shifts in the yield curve — the gap between long-term and short-term rates — because it influences lending profitability. A steeper curve can help interest earnings, while higher funding costs can offset the benefit.

A filing on Friday showed BofA Finance LLC, backed by a Bank of America guarantee, marketed auto-callable enhanced return notes tied to the least-performing of the Nasdaq-100, Russell 2000 and S&P 500 indexes, due Feb. 1, 2029. Auto-callable notes can repay early if preset thresholds are met; if the worst-performing index drops far enough, investors can lose principal. The preliminary pricing supplement said the notes are expected to price on Jan. 27 and issue on Jan. 30.

Analysts tracked by MarketWatch put a median target of $59 on Bank of America, above current levels. Their estimates ranged from $53 to $68.

Before the next session, investors will parse the U.S. Employment Situation report for December 2025, due at 8:30 a.m. ET on Jan. 9, for clues on wages and hiring.

Inflation is next. The U.S. Consumer Price Index for December 2025 is scheduled for 8:30 a.m. ET on Jan. 13, a release that can swing Treasury yields and, by extension, bank stocks.

Bank of America is due to report fourth-quarter 2025 results on Jan. 14, and it expects to release the numbers around 6:45 a.m. ET and hold an investor call at 8:30 a.m. ET, the bank said. Traders will listen for updated expectations on credit losses, deposit costs and net interest income.

From a technical standpoint, Bank of America shares are near the top of their 52-week range of $33.07 to $56.55. Friday’s trading range of $54.88 to $55.99 kept the $56 area in focus ahead of next week’s data and the start of bank earnings season.

Stock Market Today

  • Telix Pharmaceuticals Phase 3 ProstACT Safety Data Boosts Investment Outlook
    June 12, 2026, 8:05 PM EDT. Telix Pharmaceuticals (ASX:TLX) announced early Phase 3 ProstACT trial data for TLX591-Tx in metastatic castration-resistant prostate cancer, demonstrating an acceptable safety and tolerability profile with no new safety concerns. The lower kidney and salivary gland exposure compared to existing therapies could signal a differentiated advantage. This supports Telix's shift from diagnostics to higher-value therapeutics but hinges on upcoming pivotal trial results. A new U.S. collaboration with United Imaging aims to enhance theranostics workflow and commercial scale. Despite promising clinical progress, risks include regulatory scrutiny following an SEC subpoena over prostate cancer disclosures. Analysts forecast 22.7% annual revenue growth to A$1.2 billion by 2029, with an 85% upside to Telix's current price. Market watchers weigh potential regulatory and execution challenges against long-term growth prospects in theranostics.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains
Previous Story

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom
Next Story

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Go toTop